Bone health: Weight loss after GLP-1 therapy raises concerns of bone density decline, already an issue post-menopause
Akita Y, Sumino Y, Mori K, Nomura T, Sato F, Mimata H
It requires: A valid prescription from a licensed physician Compounding by a 503A (patient-specific) or 503B (outsourcing facility) pharmacy Compliance with USP standards and cGMP requirements Batch-specific testing and Certificates of Analysis For the estimated hundreds of thousands of Americans who were using Category 2 peptides, a reclassificationif it were finalizedwould mean a return to legal, quality-controlled access
J Neurosci 2002
Best practice: Match the compound to the specific cellular pathway (Systemic energy/insulin = MOTS-c, Targeted NAD+/fat loss = 5-Amino-1MQ)
They show whether your current injection frequency is keeping your levels in the optimal range or if its time to make a change